Vaccinex, Inc. (VCNX): Total Liabilities
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$5.08M
As of 2024-12-31
+27.9%
3-year compound annual growth
-5.9%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $5.08M | -14.4% | 2025-04-15, Balance as of period end |
| 2023-12-31 | $5.94M | +113.4% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $2.78M | +14.5% | 2024-04-25, Balance as of period end |
| 2021-12-31 | $2.43M | -83.0% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $14.31M | +108.1% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $6.88M | +2.9% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $6.69M | -9.0% | 2020-03-09, Balance as of period end |
| 2017-12-31 | $7.35M | n/a | 2019-03-13, Balance as of period end |